TABLE 2.

Studies on anti-parasitic therapy for neurocysticercosis

Drug, treatment length (days), dose (mg/kg)Yr first usedReference(s)
Parenchymal
    Cystic
        Praziquantel, 15, 50197913, 18, 29, 31, 32, 38, 67, 71, 72, 88, 94-96, 102
        Albendazole, 30, 15198718, 29, 49, 89, 94
        Albendazole, 8, 15198814, 55, 78, 94
        Albendazole, 21, 1519891
        Albendazole, 3, 1519893
        Praziquantel, 7, 50199035, 94
        Praziquantel, 10, 100199011
        Praziquantel, 21, 50199298
        Albendazole, 15, 15199221, 28
        Albendazole, 10, 15199572
        Albendazole, 15, 3019951
        Praziquantel, 1, 75199624, 25, 35, 69, 81
    Degenerating
        Albendazole, 15, 1519936, 36, 85
        Albendazole, 8, 15199479
        Albendazole, 30, 1519985, 6
        Praziquantel, 1, 75200080
Subarachnoid, cystic/race- mose, albendazole, 8, 1519924, 33, 77, 90
Parenchymal/subarachnoid, giant cysts
        Albendazole, 7, 15199240, 58
        Praziquantel, 15, 50a200182
        Albendazole, 30, 15a200182
        Albendazole, 7, 30200158
Ventricle, cystic
        Albendazole, 15, 15a199731, 83
        Praziquantel, 15, 100a199983
        Albendazole, 30, 15a199983
  • a Repeated courses.